Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome of HCV genotype 1 treatment in HIV-coinfected patients with chronic kidney disease.

Journal of the International Association of Providers of AIDS Care - 1 Jan 2000

Oppenheimer Ana Paula, Johnson James, Núñez Marina

Abstract excerpt

Chronic renal insufficiency is a barrier for the treatment of hepatitis C virus (HCV), and yet virus clearance is desirable prior to kidney transplantation. Several reports document success of kidney transplantation in the setting of HIV infection. We analyzed the treatment outcome of patients with HIV and HCV genotype 1 infections and chronic kidney disease, who received pegylated interferon with or without...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemoglobins
Share to Hepatitis C, Chronic
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Renal Insufficiency, Chronic

Share to Ribavirin

Share to Viral Load

Source

Identifiers

PMID: 23076663
DOI: 10.1177/1545109712461554

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of HCV genotype 1 treatment in HIV-coinfected patients with chronic kidney disease.PMID 23076663Read ↗

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.Semantic proximity Read ↗

HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin.Semantic proximity Read ↗

Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy.Semantic proximity Read ↗

Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients.Semantic proximity Read ↗

Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.Semantic proximity Read ↗

Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.Semantic proximity Read ↗

Evaluation and treatment of hepatitis C in patients with human immunodeficiency virus.Semantic proximity Read ↗

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.Semantic proximity Read ↗

Preliminary results of treatment with pegylated interferon alpha 2A for chronic hepatitis C virus in kidney transplant candidates on hemodialysis.Semantic proximity Read ↗

Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin.Semantic proximity Read ↗

Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.Semantic proximity Read ↗

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.